Top Five BioPharma Adopts LifeSphere MultiVigilance to Automate Drug Safety
Global life sciences leader will deploy ArisGlobal’s next-generation safety system, ...
ArisGlobal Announces Formation of Advisory Board, Bringing Together Industry Veterans to Guide Future Strategy
Assembly of six recognized leaders from across the life sciences ...
Former Chief Medical Officer of AbbVie, Dr. Rob Scott, Joins ArisGlobal Board of Directors
Veteran life sciences leader brings deep industry experience to help ...
ArisGlobal Announces the Appointment of Mike Gordon as Chairman of the Board of Directors
Veteran technology executive will play instrumental role in guiding ArisGlobal’s ...
ArisGlobal Announces the All-New LifeSphere® Regulatory Platform, Bringing Game-Changing Efficiency to Regulatory Information Management
LifeSphere Regulatory is a unified suite that delivers end-to-end regulatory ...
India’s Largest Biopharmaceutical Selects LifeSphere® eTMF to Streamline Clinical Trial Document Management
LifeSphere eTMF delivers easy and intuitive management of trial documentation ...
Luye Pharma Group Selects LifeSphere® Signal and Risk Management to Automate Drug Safety Signal Detection
Luye Pharma Group, an international pharmaceutical has selected LifeSphere Signal and Risk Management as its next-generation signal detection tool.
ArisGlobal Introduces LifeSphere CTMS10, Bringing Modern Simplicity and Efficiency to Clinical Trial Management
ArisGlobal announced the release of LifeSphere CTMS , a modern, end-to-end solution that makes the entire clinical trial management process easier and more transparent for companies of all sizes.
Two Top 25 Global Pharma Companies Adopt LifeSphere® Intake and Triage to Automate Adverse Event Case Processing
Two large multi-national pharmaceutical companies have selected the LifeSphere® Intake and Triage solution to bring substantial efficiency gains to adverse event case processing across their global affiliates
ArisGlobal to Co-Present “Enhancing Operations: Enabling Digital Transformation with Next-Gen Technology” at World Drug Safety Congress Americas
ArisGlobal is thrilled to announce their participation at the World Drug Safety Congress Americas, September 01 – 02, 2020. Along with a large drug manufacturer, they will be co-presenting a session titled “Enhancing Operations: Enabling Digital Transformation with Next-Gen Technology”.
